N-3 (OMEGA-3) POLYUNSATURATED FATTY ACIDS IN THE PATHOPHYSIOLOGY AND TREATMENT OF DEPRESSION: PRE-CLINICAL EVIDENCE

LEVANT, B.. (2013). N-3 (OMEGA-3) POLYUNSATURATED FATTY ACIDS IN THE PATHOPHYSIOLOGY AND TREATMENT OF DEPRESSION: PRE-CLINICAL EVIDENCE. CURRENT DRUG TARGETS CNS AND NEUROLOGICAL DISORDERS (CNS AND NEUROLOGICAL DISORDERS DRUG TARGETS), 12(4), 450-459. SID. https://sid.ir/paper/653028/en

LEVANT B.. N-3 (OMEGA-3) POLYUNSATURATED FATTY ACIDS IN THE PATHOPHYSIOLOGY AND TREATMENT OF DEPRESSION: PRE-CLINICAL EVIDENCE. CURRENT DRUG TARGETS CNS AND NEUROLOGICAL DISORDERS (CNS AND NEUROLOGICAL DISORDERS DRUG TARGETS)[Internet]. 2013;12(4):450-459. Available from: https://sid.ir/paper/653028/en

B. LEVANT, “N-3 (OMEGA-3) POLYUNSATURATED FATTY ACIDS IN THE PATHOPHYSIOLOGY AND TREATMENT OF DEPRESSION: PRE-CLINICAL EVIDENCE,” CURRENT DRUG TARGETS CNS AND NEUROLOGICAL DISORDERS (CNS AND NEUROLOGICAL DISORDERS DRUG TARGETS), vol. 12, no. 4, pp. 450–459, 2013, [Online]. Available: https://sid.ir/paper/653028/en